Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING HEREDITARY ANGIOEDEMA ATTACK
Document Type and Number:
Japanese Patent JP2022033868
Kind Code:
A
Abstract:
To provide plasma kallikrein antibodies binding to active plasma kallikrein and methods of using such antibodies in treating and preventing hereditary angioedema attack.SOLUTION: The method comprises administering to a subject in need thereof an antibody that binds to the same epitope as DX-2930 or competes against DX-2930 for binding to active plasma kallikrein at multiple doses in a first treatment period, where the antibody is administered in multiple doses of about 150 mg or about 300 mg in the first treatment period.SELECTED DRAWING: Figure 1

Inventors:
JENNIFER SCHRANZ
BURT ADELMAN
ZHANG YANG
Application Number:
JP2021195425A
Publication Date:
March 02, 2022
Filing Date:
December 01, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAKEDA CHEMICAL INDUSTRIES LTD
International Classes:
A61K39/395; A61P7/10
Foreign References:
WO2015112578A12015-07-30
WO2014152232A22014-09-25
WO2016160926A12016-10-06
Other References:
辻江 正裕、兼松 義一: "“ベイナイトレールにおける白色層発生状況調査と微小き裂の再現試験”", 日本トライボロジー学会トライボロジー会議予稿集(CD−ROM), vol. 2016秋, JPN6020003502, 22 October 2016 (2016-10-22), pages 1 - 282, ISSN: 0004938251
ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, vol. 113, no. 4, JPN6020042169, 2014, pages 460 - 466, ISSN: 0004938252
Attorney, Agent or Firm:
Ryoichi Takaoka
Nao Oda
Akiyo Iwahori
Rena Miyoshi
Kamoto Takahashi